SCHEMBL14288337

SCHEMBL14288337

CNS(=O)(=O)Nc1ccc(C(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
KDM4E B2RXH2 2/20 0.49
PGR P06401 1/20 0.49
MAPT P10636 3/20 0.49
ALDH1A1 P00352 2/20 0.49
GAA P10253 1/20 0.49
PKM P14618 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
POLB P06746 1/20 0.41
THRB P10828 1/20 0.41
KIF11 P52732 1/20 0.41
MCL1 Q07820 1/20 0.40
TRIM24 O15164 1/20 0.40
BRD1 O95696 1/20 0.40
BRPF1 P55201 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7338377 0.79 LMNA (0.45) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL9464922 0.79 KEAP1 (0.50) LMNAKDM4EMAPTALDH1A1PKM
SCHEMBL301661 0.79 LMNA (0.70) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL5630910 0.78 CA1 (0.61) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL12695023 0.78 LMNA (0.50) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL21033858 0.78 LMNA (0.51) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL15448405 0.77 CA1 (0.59) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL21150900 0.76 HPGD (0.60) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL27183190 0.76 LMNA (0.53) LMNAKDM4EPGRMAPTALDH1A1
SCHEMBL11758842 0.76 ADRB2 (0.74) LMNAKDM4EMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015190-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME CORP. 2008-01-17 US disclosed
US-20080015190-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME CORP. 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015190-A1 Inhibitors of Histone Deacetylase HDAC5, HDAC1, HDAC4 LMNA 3320/4885KDM4E 807/4885PGR 3921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.